Menu
Our story began in 2013, from theoretical musing and the hypothesis that the solubility of a substance could be determined by means of machine vision. Seeing was truly believing – the innovation opened up a completely new way to measure physicochemical properties of materials. The SPA™ technology was further refined during the years 2013-2018.
After successful proof of concept studies with some of the largest pharmaceutical companies in the world, The Solubility Company was founded in 2018 as a spin-out from the University of Helsinki. The Solubility Company provides measurement services based on the proprietary image-based SPA™ technology as a preclinical contract research organization (CRO) .
Our service laboratory is based in Helsinki, Finland and is operated by a highly skilled team with more than 50 years of experience in physical chemistry, pharmaceutical development and high-tech R&D.
Science with heart
We are a youthful and highly skilled team of professionals excited about science, technology and life.
Physical chemistry is our passion and we are here to help you and your organization deliver.
Dr. Sami Svanbäck
CEO, Member of the Board
Dr. Svanbäck is a serial entrepreneur and inventor who has led the transformation of the SPA technology from an academic project into an internationally succesful growth company.
Dr. Ville Voipio
Chairman of the Board
Dr. Voipio has over 20 years of experience in R&D, senior management and board positions of international B2B high-tech companies.
Prof. Jouko Yliruusi
Member of the Board
Prof. Yliruusi has over 40 years of experience in the pharmaceutical industry and academia and has taken part in the development over 200 drug products and several internationally successful startups.
Harry Santamäki
Head of Advisory Network
Mr. Santamäki is a successful startup accelerator and seed investor with experience in running international startups and of top positions in larger tech companies.
32nd symposium of the Finnish Society of Physical Pharmacy
Theme: Solubility and stability challenges in drug development
Date: Thu 25th of March 2021